|
CYP20A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29261054585095E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.44229073129054E-12 |
| Normal-vs-Stage2 |
8.43839999999929E-05 |
| Normal-vs-Stage3 |
4.17340000335997E-08 |
| Normal-vs-Stage4 |
1.03330000111868E-09 |
| Stage1-vs-Stage2 |
8.674800E-01 |
| Stage1-vs-Stage3 |
4.820800E-01 |
| Stage1-vs-Stage4 |
3.628000E-02 |
| Stage2-vs-Stage3 |
4.949200E-01 |
| Stage2-vs-Stage4 |
1.251030E-01 |
| Stage3-vs-Stage4 |
3.326600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68165481539972E-12 |
| Normal-vs-AfricanAmerican |
3.30689997607436E-09 |
| Normal-vs-Asian |
9.72299999957293E-07 |
| Caucasian-vs-AfricanAmerican |
3.728200E-01 |
| Caucasian-vs-Asian |
3.950400E-01 |
| AfricanAmerican-vs-Asian |
2.583200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.99440505513849E-15 |
| Normal-vs-Female |
1.70280999999273E-05 |
| Male-vs-Female |
2.977000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.21480000503382E-08 |
| Normal-vs-Extreme_Weight |
1.63935531816151E-12 |
| Normal-vs-Obese |
8.95520324561971E-11 |
| Normal-vs-Extreme_Obese |
3.69319999999895E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.153600E-01 |
| Normal_Weight-vs-Obese |
6.804000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.782400E-01 |
| Extreme_Weight-vs-Obese |
1.431810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.641000E-01 |
| Obese-vs-Extreme_Obese |
6.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32119999995961E-06 |
| Normal-vs-Age(41-60Yrs) |
6.73299971332142E-10 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(81-100Yrs) |
1.763630E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.512000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.737150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.888000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.192600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.500400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.831200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.54518628395317E-12 |
| Normal-VS-Type2 PRCC |
1.64490643328463E-12 |
| Normal-VS-KIRP CIMP |
2.97080000044581E-07 |
| Normal-VS-Unclassified PRCC |
3.564900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.722100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.785400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.674400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.200000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.688300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.613800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83562062719511E-12 |
| Normal-vs-N1 |
6.39439999949865E-07 |
| Normal-vs-N2 |
2.86429999996063E-06 |
| N0-vs-N1 |
7.181200E-01 |
| N0-vs-N2 |
5.181200E-01 |
| N1-vs-N2 |
4.472400E-01 |
|
|
